NEW YORK, Oct. 3 – Oncogenomics company Sagres Discovery said Wednesday it had raised $20 million in a second round of private financing.

Sagres of Davis, Calif., said it would use the fresh influx of funds to develop its collection of genes associated with cancer and to form deals with partners to develop antibody and small molecule treatments. The company is also planning to build its senior management and pre-clinical research teams.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.